Disc Medicine Inc (IRON)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Georges Gemayel |
| Employees: | 30 |
| Web site: | geminitherapeutics.com |
|
321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
(617) 674-9274
| |
Are you looking for this stock instead?
| Date | Ratio |
|---|---|
| 2022-12-30 | 1:30 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Gemini Therapeutics, Inc. engages in developing therapeutic compounds for treating genetically defined age-related macular degeneration (AMD) Its lead candidate is GEM103, a recombinant form of the human complement factor H protein. The company also develops GEM307 for treatment of systemic diseases.
Please log in first to see chart